These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15307326)

  • 1. Pharmacology 101 pop quiz.
    Zarbock S
    JAAPA; 2004 Feb; 17(2):13-4, 16. PubMed ID: 15307326
    [No Abstract]   [Full Text] [Related]  

  • 2. AWP reimbursement scrutinized by several states.
    Carroll J
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract]   [Full Text] [Related]  

  • 3. If foreign drug prices go up, will U.S. prices come down?
    Med Health; 2003 Dec; 57(45):2-4. PubMed ID: 14723168
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare should bargain for lower drug prices, study says.
    Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
    [No Abstract]   [Full Text] [Related]  

  • 6. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug companies defrauded Medicare of millions.
    Charatan F
    BMJ; 2001 Oct; 323(7317):828. PubMed ID: 11597964
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare & drugs: the elusive prize revisited.
    Iglehart JK
    Health Aff (Millwood); 2000; 19(2):6-7. PubMed ID: 10718017
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 11. Toward a rational, value-based drug benefit for Medicare.
    Lopert R; Moon M
    Health Aff (Millwood); 2007; 26(6):1666-73. PubMed ID: 17978385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high price of aging.
    Charatan FB
    West J Med; 2000 Jun; 172(6):363-4. PubMed ID: 10854373
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare 'reform': deep cuts likely for Medicare providers.
    Gatty B
    Geriatrics; 1994 Sep; 49(9):54-6. PubMed ID: 8088560
    [No Abstract]   [Full Text] [Related]  

  • 14. Should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Nov; 29(11):780, 782. PubMed ID: 10138575
    [No Abstract]   [Full Text] [Related]  

  • 15. When drug costs sting, look for relief.
    Schultz S
    US News World Rep; 2001 Jun; 130(22):69-70. PubMed ID: 11409347
    [No Abstract]   [Full Text] [Related]  

  • 16. Industry warily eyes new Medicare drug plan.
    Vastag B
    Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
    [No Abstract]   [Full Text] [Related]  

  • 17. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 19. Screaming for relief.
    Cooper M
    Time; 1999 Nov; 154(21):38-42, 44. PubMed ID: 10622838
    [No Abstract]   [Full Text] [Related]  

  • 20. MEDICARE Rx...help is on the way!
    Frankenburger J
    Colo Nurse; 2005 Sep; 105(3):22. PubMed ID: 16189957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.